baber/WOPTO huggingface dataset:
Patent CA-2572104-A1 (CA)
Title: Diesel engine lubricating oil composition for large-bore two-stroke cross-head diesel engines
Inventor: NAGAMATSU HIROYUKI
IPC: C10M135/12
Filed: 2006-12-27
Abstract: A lubricating oil composition comprising a base oil of lubricating viscosity having a kinematic viscosity of 22 to 300 mm2/s at 40°C and dissolved or dispersed therein the following additives in the following amounts based on a total amount of the lubricating oil composition: (1) an overbased sulfurized alkylphenol calcium salt detergent in an amount of 0.5 to 1.0 wt.% in terms of calcium content, (2) an overbased calcium alkylbenzenesulfonate detergent in an amount of 1.5 to 2.1 wt.% in terms of calcium content, (3) a nitrogen-containing ashless dispersant in an amount of 0.005 to 0.1 wt.% in terms of nitrogen content, and (4) a zinc dihydrocarbyldithiophosphate in an amount of 0.007 to 0.1 wt.% in terms of phosphorus content, wherein the weight ratio of the overbased sulfurized alkylphenol calcium salt detergent to the overbased calcium alkylbenzenesulfonate detergent is in the range of 22:78 to 37:63 in terms of calcium content and wherein the lubricating oil composition has a total base number of 60 to 100 mg.cndot.KOH/g.  The lubricating oil composition of the present invention demonstrates high temperature wear and scuffing performance.
Patent CA-2574688-A1 (CA)
Title: Curable resin composition for fuel cell electrolyte film and electrolyte film, process for producing the same, electrolyte film/electrode assembly, and process for producing the same
Inventor: KONISHI SHIGERU
IPC: C08F290/00
Filed: 2005-05-20
Abstract: A curable resin composition for fuel cell electrolyte films characterized by comprising (1) 100 parts by mass of a monomer having at least one ethylenically unsaturated group per molecule and having, per molecule, either at least one, ionically conductive group or at least one precursor group capable of giving an ionically conductive group through a chemical reaction, (2) 10-400 parts by mass of an oligomer which has, per molecule, at least two reactive groups copolymerizable with the ethylenically unsaturated group of the ingredient (1) and has a number-average molecular weight of 400 or higher, (3) 10-400 parts by mass of a fluororesin, and (4) 0-2,000 parts by mass of a solvent.
Patent CA-2575566-A1 (CA)
Inventor: ERNST PATRIK
IPC: B65G53/52
Filed: 2005-07-22
Abstract: The invention relates to a device for pneumatically conveying a free-flowing bulk material in a dense flow method, containing a cross-sectionally closed conveying line (3) with a conveying channel (2), a compressed gas auxiliary line (4) with a compressed gas channel (18), and means (5) which permit the passage of compressed gas and which serve to supply the conveying channel (2) with a compressed gas from the compressed gas channel (18). The invention is characterized in that a fluidizing device is assigned to the conveying line (3), and the fluidizing device contains a fluidizing body (6) having a fluidizing gas channel (8) and means (9) which permit the passage of fluidizing gas and which serve to supply a fluidizing gas from the fluidizing gas channel (8) and into the conveying channel (2).
Patent CA-2575977-A1 (CA)
Title: Disposable pull-on garment
Inventor: MATSUDA TOSHIYUKI
IPC: A61F13/15
Filed: 2005-08-03
Abstract: A disposable pull-on garment is disclosed. The pull-on garment has a waist opening and two leg openings and extends in a longitudinal direction and a transverse direction. The pull-on garment comprises an absorbent main body and a ring-like elastic belt. The absorbent main body comprises a liquid pervious topsheet, a liquid impervious backsheet, and an absorbent core disposed therebetween. The absorbent main body has left and right longitudinally extending side edges, front and back transversely extending end edges, longitudinally opposing front and back waist panels, and a crotch panel between the waist panels. The ring-like elastic belt comprises a front belt portion and a back belt portion. Each of the ring-like belt comprises a belt layer and a belt elastic material joined to the belt layer. Each of the ring-like elastic belt has transversely extending proximal and distal edges, longitudinally extending left and right side edges connecting the proximal and distal edges, the proximal edge being located closer than the distal edge relative to the crotch panel of the absorbent main body, a central panel, and left and right side panels contiguous with its central panel. Each side panel having a longitudinal length defined by the respective side edge of the respective belt portion. The central panel of the front belt portion is joined to the front waist panel of the absorbent main body. The central panel of the back belt portion is joined to the back waist panel of the absorbent main body. The respective left and right side panels of the front belt portion and the back belt portion are joined together at or adjacent to the respective left and right side edges to form the waist opening and the two leg openings.  The longitudinal lengths of the side panels of the back belt portion are greater than the longitudinal lengths of the respective side panels of the front belt portion.
Patent CA-2576159-A1 (CA)
Title: Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
Inventor: REMUZZI GIUSEPPE
IPC: A61P37/06
Filed: 2005-08-25
Abstract: The present invention relates to the use of an inhibitor of CDK2 and/or CDK7 and/or CDK9, or a pharmaceutically acceptable salt thereof, in the preparation of a medicament for treating a disease associated with antinuclear antibodies, wherein the inhibitor of CDK2 and/or CDK7 and/or CDK9 or pharmaceutically acceptable salt thereof is administered in an amount sufficient to down-regulate the levels of antinuclear antibodies. A further aspect of the invention relates to a combination comprising an inhibitor of CDK2 and/or CDK7 and/or CDK9, or a pharmaceutically acceptable salt thereof, and methylprednisolone, and its use in the treatment of diseases associated with antinuclear antibodies, such as SLE.
Patent CA-2578297-A1 (CA)
Title: Method of selective edge softening and rendering for the suppression of halo
Inventor: CUCIUREAN-ZAPAN CLARA
IPC: H04N1/409
Filed: 2000-11-08
Abstract: Selective edge softening and selective edge dithering is introduced into an image representation to improve local control where halo problems are expected. Selective areas of dilation are isolated and separately dithered or halftoned, the result of which is then swapped back into or substituted for the stored original image. In this manner misregistration and color plane-to-plane interactions can be compensated for in plural image forming station architecture systems. The same technique is also valuable in monochrome systems as an aid to overcoming edge displacement and slow toner problems when the selective edge softening is selectively applied to edges which are in particular perpendicular to the fast scan direction.
Patent CA-2581270-A1 (CA)
Title: Lending system and method
Inventor: COLE STEPHEN JAMES
IPC: G06Q10/00
Filed: 2005-06-22
Abstract: A lending system (10) for lending an econtent item comprises a library server (12) having a processor (13) and a number of databases (19, 24, 26). Borrowers (18) can access the system using a PDA (14) or other suitable communications device over a communications network (16) such as the Internet. Each econtent item has a number of loan instances allocated to it, and the econtent item can be made available to borrowers up to a maximum number of predetermined loan instances over a set period of time. A single loan instances can be typically defined as a period of between 5 minutes and 24 hours to a single borrower, with an econtent item having an allocation of a set number of loan instances per calendar year, for example, 325 loan instances. This allows the econtent item to be made available to multiple concurrent users or single users as long as the number of loan instances has not been exceeded in any given year.  Figure 1
Patent CA-2582027-A1 (CA)
Title: A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system
Inventor: DI MARZO VINCENZO
IPC: A61K31/7034
Filed: 2007-03-16
Abstract: The present invention relates to a pharmaceutical composition consisting of amides of mono- and di-carboxylic acids and hydroxystilbenes, and may be used for the treatment of pathologies caused, sustained and/or characterised by an abnormal general response of the immune system, in both humans and animals.
Patent CA-2582849-A1 (CA)
Title: Case for portable electronic device
Inventor: QUINTEROS ERNESTO
IPC: A45C11/00
Filed: 2007-03-27
Abstract: Cases for portable electronic devices, including cases that provide support as well as protection. Cases may be configured to contain a video-capable electronic device (601) and may both protect the device and allow it to maintain a hands-free viewing position. Embodiments include a first panel (110) having an upper portion (111) and a lower portion (112) separated from each other by a hinge line (113), a second panel (120) spaced apart from and coupled to the upper portion of the first panel by a first sidewall (160) and a second sidewall (170), and a third panel (130) spaced apart from and coupled to the lower portion of the first panel by a third sidewall (180) and a fourth sidewall (190). The first panel is capable of being folded along the hinge line into a flexed position.
Patent CA-2585062-A1 (CA)
Title: Identification of a jak2 mutation in polycythemia vera
Inventor: CASADEVALL NICOLE
IPC: C07H21/00
Filed: 2005-10-26
Abstract: An isolated JAK2 (Janus kinase 2) protein is a mutation of the amino acid 617, and especially mutation V617F, with its sequence present in SEQ ID No. 1, or a similar sequence in other mammals, is new. The nucleotide sequence coding for the variant JAK2 V617F is especially SEQ ID No 2 possessing the t/g mutation in position 1849 from the ATG marking the start of the transcription.
Patent CA-2585103-A1 (CA)
Title: Method of securing a shim to a backing plate and subassembly formed thereby
Inventor: BOSCO ROBERT R JR
IPC: F16D65/092
Filed: 2007-04-17
Abstract: A subassembly for use in a brake assembly, the subassembly comprising a shim, a backing plate and a friction pad formed of a friction pad material, wherein the friction pad material extends into at least one pass-through hole in the backing plate; and wherein one or more flanges perimetering at least one opening in the shim are encased in the friction material; whereby the shim is resisted from movement at least in part by the one or more flanges being encased in the friction pad material. A preferred methodology of forming the braking subassembly comprises the steps of forming the friction pad on the backing plate and at least partially filling the at least one pass-through hole with said friction pad material such that the one or more flanges perimetering the at least one opening in the shim is encased in the friction pad material.
Patent CA-2585165-A1 (CA)
Title: Dual antiplatelet/anticoagulant pyridoxine analogs
Inventor: KHAN A QASIM
IPC: A61K31/44
Filed: 2005-10-28
Abstract: Pyridoxine analogs , particularly bis-amidine pyridoxine analogs with antiplatelet and anticoagulant characteristics for the treatment of cardiovascular, cerebrovascular and cardiovascular related diseases and symptoms are described. The methods are directed to administering pharmaceutical compositions comprising substituted bis-amidine pyridoxine analogs having the following formulas:(I),(II),(III). wherein at least two of substituents R1- R6 have amidine groups.
Patent CA-2586216-A1 (CA)
Inventor: VOON GERARD
IPC: A61M3/00
Filed: 2007-04-19
Abstract: The invention is to boutique designer made bis peptide that are specifically fashioned to bind/lock/connect/link to the proteins (amine/carboxyl) viruses/antibiotic resistant bacteria and HIV, Cancer...(this bind(s) of amines/carboxyl can be the first line of blocking the viruses/bacteria from spreading by binding these receptors and blocking these receptors form binding with human cells).   On the other end they would bind/link/connect in a very (trying for absolute single fit for specific amine/carboxyl) between the bis peptide and nano shells (the unique fit is so neither the bis peptides nor the nano shells will bind with human cells). We will try to use the bis peptide which are bonded to the nano shells to facilitate the transport of the nano shells through the bacteria/virus cell membrane (another possibility is to attach Na2++ to the surface of the nano shell which is known to be involved in cell membrane absorption/transport in our case transporting the nano shells external to internal - possible by osmosis also). The nano shells could carry enzymes that would kill the organelles and nucleus of the bacteria/viruses, without eroding away the outer cell wall membrane of the bacteria/virus so the human body is not exposed to the enzymes. Even if it was the enzymes would be diffuse versus concentrated in a single cell. The nano shells could also contain any thing the prevents the bacteria/virus from replicating, or anything that is lethal to key bacteria/virus material (eg. nucleus, mitochondria, cytoplasm) from functioning (even possibly a very concentrated dose of salt to cause the lethal osmotic pressure bacteria/virus's membrane inner nucleus and outer membrane).     The bacteria/virus is of different concentrations of virility, shape, health/strength/activity/contagions; often in a specific area(s) of the body.   Using nano micro (multiple nano syringes in varying configurations and lengths - depending on the area of concentrations; urgent virulence - eg. to reach deeper into the body area) multiple needled syringes (which part of my invention, see DRAWING 1).   The strategy is based on where to approach the bacteria/virus. The goal is to maximize number of meetings between bis peptide (which will bind to the nano shells -containing materials lethal or crippling to the bacteria/viruses). Approach will can calculate the highest concentration areas that stick out (protrude on the fringe), the easiest to get to vs. the hardest to deliver the bis peptide (travel) or hard to spread the bis peptide that part of the body, or small concentrations and virulence sub area (whether it is possible where hard to reach area and worth the trouble - most of the major area of infection already on the road to recovery). By concentrations we mean increasing/decreasing concentration in space occupied.   Nano materials (possibly certain bis peptides) can be made to bond/link/connect with water vapour (the H20 molecules in water vapour) and used to seed clouds, the additional weight will bring the H20 down to Earth.
Patent CA-2587126-A1 (CA)
Title: Method of treating inflammation disorders using extracts of passion fruit
Inventor: WATSON RONALD ROSS
IPC: A61P19/02
Filed: 2007-05-03
Abstract: An extract of the skin or peel of passion fruit is prepared. The extract has the effect of ameliorating the symptoms of inflammation disorders, including asthma and osteoarthritis, in mammals, including humans, when administered in an effective amount.
Patent CA-2587938-A1 (CA)
Inventor: WARREN JAY A
IPC: A61N1/39
Filed: 2005-12-22
Abstract: The present invention is directed toward devices (12,32,300) configured to perform an adaptive method for initiating the charging and delivering therapy to treat patients experiencing recurrent non-sustained arrhythmic events. The adaptive methods may modify threshold used to test the persistence of an arrhythmia prior to initiating the charging sequence to deliver therapy.
Patent CA-2588713-A1 (CA)
Title: 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
Inventor: MORTIMORE MICHAEL
IPC: C07D213/75
Filed: 2005-11-21
Abstract: The present invention provides a compound of formula (I): wherein R1, R2, R3,R4,and R5 are as defined herein. The present invention also provides pharmaceutical compositions and methods using such compositions for treating a caspase-mediated diseases and processes for preparing the compounds of the invention.
Patent CA-2590254-A1 (CA)
Title: Rapamycin derivatives and the uses thereof in the treatment of neurological disorders
Inventor: GRAZIANI EDMUND IDRIS
IPC: A61K31/435
Filed: 2005-12-15
Abstract: The present invention provides compounds of the following structure, wherein R1-R9, R15, and n are defined herein. These compounds are useful in treating neurological disorders or complications due to stroke or head injury, and as neuroprotective and neuroregenerative agents.
Patent CA-2591035-A1 (CA)
Title: Novel multimeric cd40 ligands, method for preparing same and use thereof for preparing drugs
Inventor: FOURNEL SYLVIE VICTORINE LUCIE
IPC: A61K38/04
Filed: 2005-12-15
Abstract: A compound of formula (I) is described, wherein Y represents a macrocycle, the ring of which has 9 to 36 atoms, and is functionalized by three amine or COOH functions; Rc represents a group of formula H—Xa—Xb—Xc—Xd—Xe—(Xf)i—, i represents 0 or 1, Xa is in particular lysine, arginine, or ornithine residues, Xb is in particular glycine, asparagine, L-proline or D-proline residues, Xc and Xd are in particular tyrosine, phenylalanine or 3-nitrotyrosine residues, Xe and Xf are in particular amino acid residues: NH2—(CH2)n—COOH, n ranging from 1 to 10, or NH2—(CH2—CH2—O)m—CH2CH2COOH, m ranging from 3 to 6, provided that at least one of the amino acid residues Xa, Xb, Xc and Xd is different from the corresponding amino acid in the sequence of the natural CD40 143Lys-Gly-Tyr-Tyr146 fragment(SEQ ID NO: 1).
Patent CA-2591206-A1 (CA)
Title: System and method for adaptive query identification and acceleration
Inventor: ROSENGARD PHILLIP I
IPC: G06F17/30
Filed: 2005-12-22
Abstract: A data management system and method. The system is adapted to analyze a plurality of data queries and provide a metric with respect thereto. The system then orders the queries based on the metric to improve a performance parameter of the system or estimate an execution time with respect to the query. In a more specific implementation, the system includes code for analyzing a signature of each of the queries, comparing the signature to a calibrated signature and providing a signature score in response thereto. The system further includes code for estimating an execution time of at least one of the queries. The signature may be a cluster of statements in an appropriate language such as SQL (standard query language). As an alternative, the signature maybe a set of features extracted from a plurality of statements.
Patent CA-2593081-A1 (CA)
Inventor: SKULIC IVAN
IPC: F02B25/08
Filed: 2005-09-15
Abstract: The invention concerns a two-stroke internal combustion engine supplied with gasoline, diesel, fuel, or other conventional fuel comprising a piston (2) -cylinder (1) assembly, said cylinder (1) providing exhaust ports (11), said piston (2) - cylinder (1) assembly providing a head (5) slidable within said cylinder (1) between the Top Dead Centre of the piston (2) stroke and a closure position of the exhaust ports (11), said slidable head (5) providing a transfer valve (9) for fresh air or fresh air fuel mixture within the compression and burst chamber of the piston (2) - cylinder (1) assembly, sliding of said slidable head (5) inside the cylinder (1) being controlled by actuation means co-ordinated with the piston (2) actuation system, upward said slidable head (5) a fresh air or fresh air - fuel mixture system (13, 14) being provided for suction during the stroke of said slidable head (5) between the Top Dead Centre and the exhaust port (11) closure point.
Patent CA-2593552-A1 (CA)
Title: Disposable laparoscopic instrument
Inventor: JOHNSON GARY M
IPC: A61B17/32
Filed: 2006-01-18
Abstract: The invention is directed to a surgical instrument including a handle assembly and a shaft assembly. The handle assembly further includes a fixed handle and a pivoting handle. The shaft assembly extends from the handle assembly and further includes an outer tube and an inner actuation rod that slides coaxially with the outer tube. The shaft assembly includes a rotatable knob to provide 360~ rotation. The actuation rod has a proximal end and a distal end;  the proximal end has a ball end that couples with the pivoting handle to form a rotatable ball-and-socket joint. The outer tube is formed of plastic and fits over the actuation rod to function as an electrical insulator.
Patent CA-2598358-A1 (CA)
Title: Compressed air throttle device and a powder spray coating device
Inventor: MICHAEL HANSPETER
IPC: B05B12/08
Filed: 2006-02-16
Abstract: A compressed air throttle apparatus has at least one throttle valve adjusted by an electric motor, and an electric circuit fitted with contacting elements to alternatively interrupt and close the electric circuit in relation to the throttle valve settings. This throttle apparatus preferably is applicable to a compressed air path of powder spraycoating equipment.
Patent CA-2598379-A1 (CA)
Inventor: DUROCHER ERIC
IPC: F16C33/10
Filed: 2007-08-23
Abstract: A bearing housing for a gas turbine engine comprises: a bearing housing body having a bearing cavity defined therein and at least one of a built-in lubricant nozzle and a built-in scavenge hole defined therein and in fluid communication with the bearing cavity.
Patent CA-2599578-A1 (CA)
Title: Comb-like polyetheralkanolamines in inks and coatings
Inventor: NGUYEN DUY T
IPC: C09K23/00
Filed: 2006-08-09
Abstract: The invention provides a composition comprising: (a) a pigment component; (b) a dispersant for dispersing the pigment component wherein the dispersant is present in an effective pigment-dispersing amount and has the structure: (see above formula) ; and (c) a grind resin, wherein the grind resin comprises i) a styrene, substituted-stryene monomer, or combinations thereof and ii) a carboxylated monomer, wherein the carboxylated monomer is selected from the group consisting of acrylic acid, methacrylic acid, maleic acid, half esters of maleic acid, citraconic acid, itaconic acid, and combinations thereof, wherein the acrylic acid, the methacrylic acid, the maleic acid, the half esters of maleic acid, the citraconic acid and the itaconic acid are each substituted or unsubstituted; and wherein the amount of the dispersant is from 0.5 to 25 % by weight, based on the total weight of all pigment solids in the composition. The composition may be used for coating an article.
Patent CA-2599671-A1 (CA)
Title: A method of transmitting broadcast message in a mobile communication system
Inventor: KYUNG CHAN HO
IPC: H04W48/10
Filed: 2006-02-13
Abstract: A method of transmitting a broadcast message using a Forward Common Control Channel (F-CCCH) in a wireless communication system is disclosed. More specifically, a base station determines whether a periodic enhanced broadcast page is enabled or disabled, and then transmits at least one broadcast message via a first slot of a broadcast paging cycle of the F-CCCH if determined that the periodic enhanced broadcast page is enabled.
Patent CA-2600951-A1 (CA)
Inventor: POHL JENS
IPC: C12N15/63
Filed: 2006-03-03
Abstract: The invention relates to novel biosynthetic growth factor mutants which exhibit improved biological activity.
Patent CA-2602099-A1 (CA)
Title: Methods for treating or preventing acute myelogenous leukemia
Inventor: BHAGWAT SHRIPAD S
IPC: A61K31/4196
Filed: 2006-03-21
Abstract: This invention is generally directed to methods for treating or preventing acute myelogenous leukemia ("AML") comprising administering to a patient in need thereof an effective amount of an Indazole Compound having the structure:  or a pharmaceutically acceptable salt, solvate, hydrate, prodrug, stereoisomer or enantiomer thereof, wherein R1, R2 and A are as defined herein.